Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Ugeskrift for Laeger|September 8, 2009
[Trichinellosis after consumption of meat imported from Poland]Caspar da Cunha-Bang, Suzanne LundingDrugs|November 4, 2018
Targeting Bruton's Tyrosine Kinase Across B-Cell MalignanciesCaspar da Cunha-Bang, Carsten Utoft NiemannUgeskrift for Laeger|October 28, 2021
[Chronic lymphocytic leukaemia]Caspar da Cunha-Bang, Christian Brighel, Carsten Utoft NiemannBlood Advances|March 1, 2024
It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemiaChristian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, et al.Blood|May 19, 2022
Patients with CLL have a lower risk of death from COVID-19 in the Omicron eraCarsten U Niemann, Caspar da Cunha-Bang, Marie Helleberg, et al.Leukemia|February 19, 2021
Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of deathEmelie Curovic Rotbain, Carsten Utoft Niemann, Klaus Rostgaard, et al.Clinical Epidemiology|January 10, 2022
Healthcare Utilization and Comorbidity in Chronic Lymphocytic LeukemiaEmelie C Rotbain, Klaus Rostgaard, Michael A Andersen, et al.Haematologica|May 9, 2024
The diversity of the microbiome impacts chronic lymphocytic leukemia development in mice and humansTereza Faitova, Mariana Coelho, Caspar Da Cunha-Bang, et al.British Journal of Haematology|February 11, 2021
Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based studyCaspar da Cunha-Bang, Klaus Rostgaard, Michael A Andersen, et al.BMJ Open|March 6, 2019
Risk factors associated with Richter's transformation in patients with chronic lymphocytic leukaemia: protocol for a retrospective population-based cohort studyMariam Hussein Hleuhel, Yasmin Ben-Dali, Caspar Da Cunha-Bang, et al.Pageof 5